Stock BSLN BASILEA PHARMACEUTICA AG
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Basilea Pharmaceutica AG

Equities

BSLN

CH0011432447

Market Closed - Swiss Exchange
Other stock markets
 11:31:29 2024-06-10 am EDT 		5-day change 1st Jan Change
41.85 CHF -0.83% Intraday chart for Basilea Pharmaceutica AG -4.12% +18.56%
May. 16 Basilea Pharmaceutica Receives Milestone Payment from Pfizer for Cresemba Sales MT
May. 16 Strong Cresemba(R) (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea DJ

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Stronger-than-Expected US Inflation Rate Weighs on Swiss Equities
MT
Swiss Equities Rise as Unemployment Rate Falls
MT
Basilea Pharmaceutica's Derazantinib Shows High Disease Control Rate in Bile Duct Cancer Patients
MT
BASILEA PHARMACEUTICA : Edison Investment Research Lowers Price Target on Basilea Pharmaceutica
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BSLN Stock
  4. News Basilea Pharmaceutica AG
  5. Analyst Reco.